Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxfendazole vs Albendazole for Trichuris Trichiura Infection
NCT02636803Phase 2Withdrawn
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Nov 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of oxfendazole in trichuriasis (4 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoints: Cure of Trichuris trichiura at 21 days and Reduction in Trichuris trichiura eggs at 21 days. Planned start Nov 2019; status: withdrawn.
02
Drugs
oxfendazole
03
Conditions
trichuriasis
Beyond the preview
Go deeper on NCT02636803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636803.